2 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Morten Schou: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy Digital letter - Heart Failure | Not applicable | Completed | Morten Schou | 5996 | 2023-05-03 | 2026-04-13 |
| Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction Empagliflozin 10 MG, Placebo - Heart Failure With Reduced Ejection Fraction | Phase 2 | Completed | Morten Schou | 190 | 2017-06-29 | 2020-02-05 |
Heart Failure (1)
empagliflozin (1)
Denmark (2)
PMID 31227014, PMID 33357505, PMID 33404637, PMID 34061581, PMID 34509409, PMID 34743533, PMID 35219331, PMID 35973031, PMID 39843293, PMID 40502611, PMID 41711194
2017 (1)